Cook, Perry Cole

Publications

Sort by

Co-Author Network

selected publications

Feasibility and efficacy of local radiotherapy with concurrent novel agents in patients with multiple myeloma. Clinical lymphoma, myeloma & leukemia. 2014 Academic Article GET IT
Times cited: 12
Subcutaneous administration of alemtuzumab in patients with highly active multiple sclerosis. 2012 GET IT
Times cited: 7
Evaluating the role of prophylaxis in the management of invasive fungal infections in patients with hematologic malignancy. European journal of haematology. 2011 Review GET IT
Times cited: 34
Multiple myeloma involving skin and pulmonary parenchyma after autologous stem cell transplantation. Journal of hematology & oncology. 2009 Letter GET IT
Times cited: 7
Fibroblast growth factor receptor-1 is expressed by endothelial progenitor cells. Blood. 2002 Academic Article GET IT
Times cited: 85
Classifying chronic myelomonocytic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2001 Letter GET IT
Times cited: 3
Monocytic leukemia cutis diagnosed simultaneously with refractory anemia with monocytosis: a case report. 2001 GET IT
Times cited: 2
Philadelphia-negative chronic myelogenous leukemia in a patient with a unique complex translocation: 46,XY,t(9;12;15)(q34;12;q21). 1998 GET IT
Times cited: 2
Single and double autotransplants for relapsing/refractory Hodgkin's disease: results of two consecutive trials. Bone marrow transplantation. 1997 Academic Article GET IT
Times cited: 23
Treatment of recurrent malignant glioma with BCNU-fluosol and oxygen inhalation. A phase I-II study. Journal of neuro-oncology. 1997 Academic Article GET IT
Times cited: 20
Response of human multiple myeloma-derived cell lines to alkyl-lysophospholipid. Experimental hematology. 1996 Academic Article GET IT
Times cited: 8
Transfer of human adenine deaminase gene into murine hematopoietic stem cells: sequential study of spleen colony-forming units from bone marrow of living mice and the requirement of the microenvironment. Acta haematologica. 1996 Academic Article GET IT
Times cited: 3
Outbreak of vancomycin-, ampicillin-, and aminoglycoside-resistant Enterococcus faecium bacteremia in an adult oncology unit. Antimicrobial agents and chemotherapy. 1994 Academic Article GET IT
Times cited: 292
Phase I-II trial of high dose Ara-C, carboplatinum, etoposide and steroids in patients with refractory or relapsed lymphomas. Leukemia. 1994 Academic Article GET IT
Times cited: 9
Clinical and laboratory comparison study of refrigerated and cryopreserved bone marrow for transplantation. Bone marrow transplantation. 1994 Academic Article GET IT
Times cited: 27
Treatment of gancyclovir resistant cytomegalovirus with foscarnet: a report of two cases occurring after bone marrow transplantation. 1994 GET IT
Times cited: 13
Allogeneic marrow transplantation for myelodysplastic syndrome complicating autologous bone marrow transplantation. 1994 GET IT
Times cited: 1
Blood progenitor cells: collection techniques and applications. Cancer investigation. 1994 Review GET IT
Times cited: 4
Incidence and treatment of tumor lysis syndrome in patients with acute leukemia. Acta haematologica. 1994 Academic Article GET IT
Times cited: 56
Peripheral blood mononuclear mobilization with sargramostim (GM-CSF). Progress in clinical and biological research. 1994 Academic Article GET IT
TMJ: a well-tolerated high-dose regimen for the adjuvant chemotherapy of high risk breast cancer. Journal of medicine. 1994 Academic Article GET IT
Times cited: 8
Propantheline prevention of mucositis from etoposide. Bone marrow transplantation. 1993 Academic Article GET IT
Times cited: 37
Homoharringtonine in combination with cytarabine for patients with acute myelogenous leukemia. Leukemia. 1992 Academic Article GET IT
Times cited: 47
Homoharringtonine is safe and effective for patients with acute myelogenous leukemia. Leukemia. 1992 Academic Article GET IT
Times cited: 49
Amsacrine retains a special role supporting Food and Drug Administration approval. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 1992 Letter GET IT
Times cited: 1
Higher cure rates in acute leukemia: now more probable with increasingly effective induction therapy. International journal of clinical & laboratory research. 1992 Review GET IT
Times cited: 1
Improving the "quality of remission induction" therapy: a necessary step for increasing the cure rate in acute myelogenous leukemia. Cancer investigation. 1992 Editorial Article GET IT
Specificity of heme for hemopoietic recovery from AZT toxicity. Hematologic pathology. 1992 Academic Article GET IT
Times cited: 9
Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemia. Cancer. 1991 Academic Article GET IT
Times cited: 22
Short course high dose mitoxantrone with high dose cytarabine is effective therapy for adult lymphoblastic leukemia. Leukemia. 1991 Academic Article GET IT
Times cited: 22
"Quality" remissions: a new target of induction therapy in acute leukemia and the next step in developing curative treatment. Seminars in hematology. 1991 Review GET IT
Times cited: 11
Danazol for lupus thrombocytopenia. 1985 GET IT
Times cited: 19

more ...

less ...

Background

education and training

M.D., University of Iowa College of Medicine 1977
B.A., Cornell University 1972

Contact

full name

Perry Cole Cook

primary email

pec9040@nyp.org

VIVO Weill Cornell Medical College

Perry Cole Cook Assistant Professor of Clinical Medicine

Publications

selected publications

Background

education and training

Contact

full name

primary email

Phone

Publications

selected publications

Background

education and training

Contact

full name

primary email